Neonatal Screening for Medium-Chain Acyl-CoA Deficiency—Insights and Unexpected Challenges
With the implementation of tandem mass spectrometry (MS/MS), neonatal screening for medium-chain acyl-CoA dehydrogenase (MCADD) has been introduced in many screening programs worldwide. Together with phenylketonuria, MCADD is the disorder most frequently diagnosed. Despite undeniable beneficial effe...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-11-01
|
Series: | International Journal of Neonatal Screening |
Subjects: | |
Online Access: | http://www.mdpi.com/2409-515X/1/3/79 |